Padmashree Gehl Sampath is an author, academic and policy expert, whose work is situated at the nexus of trade, technology, and industrialization. Born and educated in India, Germany and the USA, she has been a fellow both at the University of Oxford (UK), and University of Berkeley (California) during her education. With an academic background in engineering, economics, and the law, she conducts interdisciplinary work on the impact of technological change on industrialization and society. Her work has come to specialize in three sectors, which have now come to be known as the so-called grand challenges – pharmaceuticals and health, the digital economy, and energy and climate change. She serves on the Editorial Board of the Journal of Competition and Change, and her research has appeared or is forthcoming in the Michigan Journal of International Law, Harvard International Review, Harvard Public Health Review, and several other reputable outlets.
About Me
Padmashree is currently the i. Chief Executive Officer of the African Pharmaceutical Technology Foundation, and a Senior Advisor to the President of the African Development Bank. Until recently, she was a Fellow at the Berkman Klein Center, Harvard University and a Director of the Global Access in Action Program at the Center. She is an Honorary Professor, University of Rwanda and a Visiting Professor at the University of Johannesburg. She also leads a large international team examining the politics of vaccine production in Africa, as part of the Programme on Accelerating Vaccine Production in Africa: A Centres of Excellence Initiative. She is also a Professorial Fellow at the United Nations University-MERIT.
Forthcoming Talks
Accelerating Sustainable Regional Vaccine Manufacturing Through Global Partnerships | Cape Town, South Africa
EVENT: 24th DCVMN International Annual General Meeting
DATE AND TIME: 19th – 21st September, 2023
Agenda setting for the Genomics Centres of Excellence in Africa
EVENT: At the Science Summit at United Nations General Assembly (UNGA78), New York
DATE AND TIME: Sept 15th 2023, 10:30 to12 noon
Public Commentary And Advisory Activities
She is one of the original thinkers on new paradigms for international technology transactions that can better secure global public goods, particularly in the areas of pharmaceuticals and climate change: two sectors with high global relevance. In this capacity, she engages in public commentary and advisory roles that shape emerging policy. She serves as the Chairperson of the Technical Advisory Group of the COVID-19 Technology Access Pool (CTAP) of the World Health Organization since 2021 owing to her expertise on technology transfer and technological licensing.
She is currently also the Senior Advisor to the President of the African Development Bank on Pharmaceuticals and Health and the Strategic Advisor on vaccine production, advising the Ministry of Economic Development and Cooperation (BMZ) and the German International Agency (GIZ) on these issues since 2021. She has recently servied on the Partnership on African Vaccine Manufacturing Scientific Review Committee of the Africa-CDC, and routinely advises international agencies such as the United Nations Development Program, International Labour Organisation and the International Renewable Energy Agency.
Areas of Research and Practice
Forthcoming Reports
A Technology Gaps Assessment of Ghana’s Vaccine Ecosystem, A AVPA Publication, 2023
Ghana has been one of the frontrunner countries in Africa, setting up a national vaccine committee, and then a national vaccine institute to address the lack of production capacity in the African region. This study, co-authored with Bertha Vallejo, presents an in-depth picture of the state of Ghana’s vaccine production ecosystem with some thoughts on how to move ahead.
Regionalizing Pharmaceutical Production and Innovation, A joint UNDP-UNESCAP Publication, 2023
COVID-19 has caused a new wave of thinking on regionalizing production. The paper, co-authored with Fred Abbott, begins with a discussion on regionalizing production from a development and health perspective. It then proceeds to discuss the variety of models available to choose from, highlighting questions of technology, financing and other production incentives. In its final section, it discusses governance issues, and the political and policy decisions that may effectively influence the regionalization of pharmaceutical production.
Forthcoming Articles
Technological Capabilities for Local Production of Vaccines: The mRNA Hub in South Africa’ Forthcoming
This paper looks at how social capabilities serve as a catalyst for transformation in vaccine production, by conducting a case study of the mRNA Hub that is currently underway in South Africa. While the technology transfer initiative is expected to set up the most advanced facility in the African region, the paper looks at whether and under what circumstances, South Africa could harness this initiative to improve the overall knowledge base and benefit more systematically to build a vaccines sector.
Government as a Platform: Reactive vs Proactive Competition Strategies for Digital Development, Forthcoming.
This article explores the proverbial market -State regulation debate and advances the notion of how a techno-legal solution of the government-as-a-platform can help resolve most issues of accountability and competition in the new data economy.
Forthcoming Book Chapter
‘International Code of Conduct on Transfer of Technology’, in Irini Stamatoudi, Marco Ricolfi, Peter Yu and Paul Torremans (eds), Encyclopedia of Intellectual Property Law, Edward Elgar Publishing, 2023
This paper is an entry on the history and import of the International Code of Conduct on the Transfer of Technology, and how that relates to the technology transfer dilemmas we face today.
Projects
Padmashree’s work is funded by different international grants from international agencies, donor organisations and the private sector.
Her current (live) projects include:
-
This project is one of the first efforts to create a centres of excellence initiative in Africa to build R&D ecosystems to support pharmaceutical and vaccine production.
-
This is a project with colleagues from the African Development Bank, seeking to generate new data and analysis on reinforcing transformation through industrialisation can be facilitated differentially in the region.
-
This project looks at what it takes to reach zero emissions by 2050 in the various hard to decarbonize sectors, with a specific focus on the regional dimensions of industrialization, & equity.